The Trump administration has made the decisive move to terminate The Healthcare Infection Control Practices Advisory Committee (HICPAC). This committee, a pillar in the healthcare field for more than three decades, has been instrumental in shaping infection prevention protocols for healthcare facilities across the U.S.A. The sudden dismantlement of HICPAC has caused a wave of concern among infectious disease experts. This action is part of broader efforts to reduce the federal workforce. The committee received the formal termination notification from the Centers for Disease Control and Prevention (CDC) recently, however, the committee ceased to function effectively from 31st March.
Created in 1991, HICPAC comprised of 14 non-federal experts specializing in areas such as infectious diseases, infection prevention, healthcare epidemiology, nursing, and public health. Their meetings, conducted at CDC headquarters in Atlanta, were open to the public, promoting transparency in infection control guideline development. They made a notable contribution over their 33-year history, delivering 540 evidence-based recommendations. About 90% of these have been successfully implemented in healthcare facilities nationwide. The guidelines covered essential aspects of healthcare, such as patient care precautions, infection control, isolation protocols, and methods for sterilizing medical equipment.
In the backdrop of the HICPAC’s disbandment, the U.S. has been witnessing a significant rise in healthcare-associated infections. CDC data shows a 20% increase in six bacterial antimicrobial-resistant hospital-onset infections during the COVID-19 pandemic compared to pre-pandemic times. The concern about the termination of HICPAC has pushed several professional societies to pen a joint letter to Health and Human Services Secretary Robert F. Kennedy Jr. in March, advocating the preservation of HICPAC amid federal health agency reductions.
The disbandment of HICPAC creates a critical void in national preparedness, especially now, when threats from emerging pathogens and antimicrobial resistance are escalating. The guidelines provided are like a staple reference which could now potentially be outdated in this fast-paced context. Hospitals and healthcare systems need frequent updates from HICPAC to maintain consistency in their approach while dealing with infections. Their absence could build a recipe for confusion for healthcare personnel transitioning between facilities and jeopardize patient safety.
Future developments, such as how infection control guidelines will be revised and developed, are still shrouded in ambiguity, especially with the CDC and Department of Health and Human Services yet to respond. As this move comes as part of President Trump’s executive order aimed at shrinking the federal bureaucracy, it remains to be seen how this vacuum will be filled, and who will take up the mantle that HICPAC carried for over three decades. Concerning new infectious threats, healthcare facilities are nervously anticipating the support they will receive, as HICPAC’s role in rapid guideline development during public health emergencies has been invaluable.